“Synthesis and docking studies of new 5-bromoindole-2-carboxylic acid oxadiazole derivatives as EGFR inhibitors” (2023) Tikrit Journal of Pharmaceutical Sciences, 17(1), pp. 58–77. doi:10.25130/tjphs.2023.17.1.6.58.77 .